Edition:
India

People: Albireo Pharma Inc (ALBO.OQ)

ALBO.OQ on NASDAQ Stock Exchange Capital Market

17.82USD
10:49pm IST
Change (% chg)

$-0.25 (-1.41%)
Prev Close
$18.07
Open
$18.06
Day's High
$18.29
Day's Low
$17.74
Volume
6,218
Avg. Vol
19,098
52-wk High
$38.48
52-wk Low
$16.26

Harford, Simon 

Mr. Simon N.R. Harford is Chief Financial Officer, Treasurer of the Company. He has served as our Chief Financial Officer and Treasurer since October 2018. Mr. Harford previously served as Senior Vice President and Chief Financial Officer at PAREXEL International Corporation, a global clinical research organization, from May 2017 to October 2018. Prior to that, he served in several leadership roles at GlaxoSmithKline plc, a global healthcare company ("GSK"), including serving as Senior Vice President, Finance, Global Pharmaceuticals from March 2015 to April 2017, Senior Vice President, Finance, Europe and Emerging Markets from March 2014 to February 2015, and Senior Vice President, Finance, Emerging Markets from June 2009 to February 2014. Prior to joining GSK, Mr. Harford served as Group Vice President and Controller for Avon Products, Inc., a beauty products company. Additionally, he spent two decades with Eli Lilly and Company, a pharmaceutical company, in various international leadership roles, including as Vice President and Controller. Mr. Harford received an MBA from the University of Virginia's Darden Graduate School of Business.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Chiswell

195,084

Ronald Cooper

3,618,630

Simon Harford

--

Jan Mattsson

1,404,280

Martha Carter

1,243,480

Patrick Horn

--
As Of  31 Dec 2018